beta

AGTC

Applied Genetic Technologies Corporation

Agtc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

11-08-2018 09-10-2018 after market close 05-08-2018 after market close 02-09-2018 11-07-2017 after market close 09-13-2017 05-10-2017 after market close 02-08-2017 after market close 11-08-2016 after market close
Actual EPS 0.07 -0.37 -0.45 -0.29 -0.08 -0.18 -0.05 0.11 0.2
Consensus EPS -0.5 -0.23 -0.25 -0.09 -0.14 0.22 -0.02 0.03 -0.1
Estimated EPS -0.5 -0.23 -0.25 -0.09 -0.14 0.22 -0.02 0.03 -0.1
Number of Estimates 2 3 3 3 3 3 5 3 5
EPS Surprise $0.57 -$0.14 -$0.20 -$0.20 $0.06 -$0.40 -$0.03 $0.08 $0.30

Stats

Summary

Applied Genetic Technologies Corp is a clinical-stage biotechnology company focused on gene therapy through a nontoxic adeno-associated virus. The company also offers products such as promoters, expression cassettes, and capsids for gene therapy.

Market Cap: 85 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.agtc.com

Shares Outstanding: 18.1 Million

Float: 18 Million

Dividend: 0.0 (0.0%)

Beta: 1.941939

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 217 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1126 trading days

From: 2014-06-18 To: 2018-12-14

Lowest Point:

XPO, SRC, LLNW and TLRD among notable midday movers

via: SeekingAlpha at 2018-12-13 12:43:03:000

Gainers: Spirit Realty Capital (NYSE: SRC ) +421% . Adial Pharmaceuticals (NASDAQ: ADIL ) +63% . Yulong Eco-Materials Limited (NASDAQ: YECO ) +26% . Qudian (NYSE: QD ) +25% . Kezar Life Sciences (NASDAQ: KZR ) +21% . Qutoutiao (NASDAQ: QTT ) +17% . Marin Software (NASDAQ: MRIN … read more...

XPO, SRC, LLNW and TLRD among notable midday movers

via: SeekingAlpha at 2018-12-13 12:43:03:000

Gainers: Spirit Realty Capital (NYSE: SRC ) +421% . Adial Pharmaceuticals (NASDAQ: ADIL ) +63% . Yulong Eco-Materials Limited (NASDAQ: YECO ) +26% . Qudian (NYSE: QD ) +25% . Kezar Life Sciences (NASDAQ: KZR ) +21% . Qutoutiao (NASDAQ: QTT ) +17% . Marin Software (NASDAQ: MRIN … read more...

XPO, SRC, LLNW and TLRD among notable midday movers

via: SeekingAlpha at 2018-12-13 12:43:03:000

Gainers: Spirit Realty Capital (NYSE: SRC ) +421% . Adial Pharmaceuticals (NASDAQ: ADIL ) +63% . Yulong Eco-Materials Limited (NASDAQ: YECO ) +26% . Qudian (NYSE: QD ) +25% . Kezar Life Sciences (NASDAQ: KZR ) +21% . Qutoutiao (NASDAQ: QTT ) +17% . Marin Software (NASDAQ: MRIN … read more...

Healthcare and consumer stocks down in premarket trade

via: SeekingAlpha at 2018-12-13 09:12:40:000

Applied Genetic Technologies (NASDAQ: AGTC ) -38% after gene therapy fails to show effect in XLRS study. More news on: Applied Genetic Technologies Corporation, Tailored Brands, Inc, Marinus Pharmaceuticals, Stocks on the move, , Read more … read more...

Healthcare and consumer stocks down in premarket trade

via: SeekingAlpha at 2018-12-13 09:12:40:000

Applied Genetic Technologies (NASDAQ: AGTC ) -38% after gene therapy fails to show effect in XLRS study. More news on: Applied Genetic Technologies Corporation, Tailored Brands, Inc, Marinus Pharmaceuticals, Stocks on the move, , Read more … read more...

Healthcare and consumer stocks down in premarket trade

via: SeekingAlpha at 2018-12-13 09:12:40:000

Applied Genetic Technologies (NASDAQ: AGTC ) -38% after gene therapy fails to show effect in XLRS study. More news on: Applied Genetic Technologies Corporation, Tailored Brands, Inc, Marinus Pharmaceuticals, Stocks on the move, , Read more … read more...

After hours: VVUS leads gainers, losers include HASI and TLRD

via: SeekingAlpha at 2018-12-12 17:35:59:000

Top Gainers: VVUS +6.0% . GSM +5.0% . ESTE +4.6% . VSI +3.6% . ADC +2.8% . More news on: Vivus, Inc., Ferroglobe PLC, Earthstone Energy, Inc., Stocks on the move, , Read more … read more...

Applied Genetic Tech's gene therapy fails to show effect in XLRS study; Biogen collaboration terminated

via: SeekingAlpha at 2018-12-12 16:26:04:000

Thinly traded Applied Genetic Technologies (NASDAQ: AGTC ) is set for a significant down move after announcing unsuccessful results from a Phase 1/2 clinical trial assessing gene therapy rAAV2tYF-CB-hRS1 in patients with an inherited retinal disorder called X-linked retinoschisis (XLRS)…. read more...

Applied Genetic Technologies Corporation (AGTC) CEO Susan Washer on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-11 09:32:05:000

Applied Genetic Technologies Corporation (AGTC) Q1 2019 Earnings Conference Call November 8, 2018 08:00 ET Executives Susan Washer - President & CEO Matthew Feinsod - Interim Chief Medical Officer William Sullivan - CFO Analysts Matthew Luchini - BMO Capital Markets J… read more...

Applied Genetic Technologies Corporation (AGTC) CEO Susan Washer on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-11 09:32:05:000

Applied Genetic Technologies Corporation (AGTC) Q1 2019 Earnings Conference Call November 8, 2018 08:00 ET Executives Susan Washer - President & CEO Matthew Feinsod - Interim Chief Medical Officer William Sullivan - CFO Analysts Matthew Luchini - BMO Capital Markets J… read more...

Applied Genetic Technologies Corporation (AGTC) CEO Susan Washer on Q1 2019 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-11-11 09:32:05:000

Applied Genetic Technologies Corporation (AGTC) Q1 2019 Earnings Conference Call November 8, 2018 08:00 ET Executives Susan Washer - President & CEO Matthew Feinsod - Interim Chief Medical Officer William Sullivan - CFO Analysts Matthew Luchini - BMO Capital Markets J… read more...

Applied Genetic reports Q1 results

via: SeekingAlpha at 2018-11-08 07:09:56:000

Applied Genetic (NASDAQ: AGTC ): Q1 GAAP EPS of $0.07. More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Applied Genetic reports Q1 results

via: SeekingAlpha at 2018-11-08 07:09:56:000

Applied Genetic (NASDAQ: AGTC ): Q1 GAAP EPS of $0.07. More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Applied Genetic reports Q1 results

via: SeekingAlpha at 2018-11-08 07:09:56:000

Applied Genetic (NASDAQ: AGTC ): Q1 GAAP EPS of $0.07. More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Midday Gainers / Losers (09/25/2018)

via: SeekingAlpha at 2018-09-25 12:53:45:000

Gainers: EDRY +34% . OASM +32% . XOXO +26% . AGTC +26% . OXFD +19% . SONC +18% . TRT +17% . ALRN +17% . I +17% . TLRY +15% . More news on: EuroDry Ltd., Oasmia Pharmaceutical, XO Group Inc., Stocks on the move, , Top stock market news, Read more ….. read more...

Midday Gainers / Losers (09/25/2018)

via: SeekingAlpha at 2018-09-25 12:53:45:000

Gainers: EDRY +34% . OASM +32% . XOXO +26% . AGTC +26% . OXFD +19% . SONC +18% . TRT +17% . ALRN +17% . I +17% . TLRY +15% . More news on: EuroDry Ltd., Oasmia Pharmaceutical, XO Group Inc., Stocks on the move, , Top stock market news, Read more ….. read more...

Midday Gainers / Losers (09/25/2018)

via: SeekingAlpha at 2018-09-25 12:53:45:000

Gainers: EDRY +34% . OASM +32% . XOXO +26% . AGTC +26% . OXFD +19% . SONC +18% . TRT +17% . ALRN +17% . I +17% . TLRY +15% . More news on: EuroDry Ltd., Oasmia Pharmaceutical, XO Group Inc., Stocks on the move, , Top stock market news, Read more ….. read more...

Nightstar Therapeutics: Sell-Off Is A Great Entry Point For Long-Term Investors

via: SeekingAlpha at 2018-09-25 11:40:21:000

Last weekend, Nightstar Therapeutics (NASDAQ: NITE ) had a highly notable catalyst event in the form of preliminary data for its Phase 1/2 XIRIUS Trial for the treatment of X-linked Retinitis Pigmentosa (XLRP) at EURETINA 2018, and a subsequent R&D Day on Monday with further explanation of… read more...

Nightstar Therapeutics: Sell-Off Is A Great Entry Point For Long-Term Investors

via: SeekingAlpha at 2018-09-25 11:40:21:000

Last weekend, Nightstar Therapeutics (NASDAQ: NITE ) had a highly notable catalyst event in the form of preliminary data for its Phase 1/2 XIRIUS Trial for the treatment of X-linked Retinitis Pigmentosa (XLRP) at EURETINA 2018, and a subsequent R&D Day on Monday with further explanation of… read more...

Nightstar Therapeutics: Sell-Off Is A Great Entry Point For Long-Term Investors

via: SeekingAlpha at 2018-09-25 11:40:21:000

Last weekend, Nightstar Therapeutics (NASDAQ: NITE ) had a highly notable catalyst event in the form of preliminary data for its Phase 1/2 XIRIUS Trial for the treatment of X-linked Retinitis Pigmentosa (XLRP) at EURETINA 2018, and a subsequent R&D Day on Monday with further explanation of… read more...

Midday Gainers / Losers (09/24/2018)

via: SeekingAlpha at 2018-09-24 12:35:13:000

Gainers: AMRN +233% . SAEX +153% . GBR +41% . JONE +27% . IPCI +26% . XON +23% . CRC +17% . AGTC +16% . PEIX +15% . ACHV +15% . More news on: Amarin Corporation PLC, SAExploration Holdings, Inc., New Concept Energy, Inc., , Stocks on the move, Top stoc… read more...

Applied Genetic Tech up 10%

via: SeekingAlpha at 2018-09-24 10:03:23:000

Thinly traded nano cap Applied Genetic Technologies ( AGTC +10.2% ) is up on almost a 4x surge in volume, albeit on turnover of only 315K shares, in apparent response to gene therapy peer Nightstar Therapeutics' announcement of positive preliminary data from a study of its gene therapy for… read more...

Premarket Gainers as of 9:05 am (09/24/2018)

via: SeekingAlpha at 2018-09-24 09:20:17:000

AMRN +280% on positive results from REDUCE-IT study. More news on: Amarin Corporation PLC, AzurRX Biopharma, Applied Genetic Technologies Corporation, Stocks on the move, , Top stock market news, Read more … read more...

Applied Genetic Technologies Corporation (AGTC) CEO Susan Washer on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-09-10 19:18:06:000

Applied Genetic Technologies Corporation (AGTC) Q4 2018 Results Earnings Conference Call September 10, 2018 04:30 PM ET Executives Susan Washer - CEO Bill Sullivan - CFO Mark Shearman - Chief Scientific Officer Analysts Matthew Luchini - BMO Capital Markets Yanan Zhu - We… read more...

Applied Genetic Technologies Corporation (AGTC) CEO Susan Washer on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-09-10 19:18:06:000

Applied Genetic Technologies Corporation (AGTC) Q4 2018 Results Earnings Conference Call September 10, 2018 04:30 PM ET Executives Susan Washer - CEO Bill Sullivan - CFO Mark Shearman - Chief Scientific Officer Analysts Matthew Luchini - BMO Capital Markets Yanan Zhu - We… read more...

Applied Genetic Technologies Corporation (AGTC) CEO Susan Washer on Q4 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-09-10 19:18:06:000

Applied Genetic Technologies Corporation (AGTC) Q4 2018 Results Earnings Conference Call September 10, 2018 04:30 PM ET Executives Susan Washer - CEO Bill Sullivan - CFO Mark Shearman - Chief Scientific Officer Analysts Matthew Luchini - BMO Capital Markets Yanan Zhu - We… read more...

Applied Genetic misses by $0.20, misses on revenue

via: SeekingAlpha at 2018-09-10 16:06:48:000

Applied Genetic (NASDAQ: AGTC ): Q4 GAAP EPS of -$0.37 misses by $0.20 . More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Applied Genetic misses by $0.20, misses on revenue

via: SeekingAlpha at 2018-09-10 16:06:48:000

Applied Genetic (NASDAQ: AGTC ): Q4 GAAP EPS of -$0.37 misses by $0.20 . More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Applied Genetic misses by $0.20, misses on revenue

via: SeekingAlpha at 2018-09-10 16:06:48:000

Applied Genetic (NASDAQ: AGTC ): Q4 GAAP EPS of -$0.37 misses by $0.20 . More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

After Hours Gainers / Losers (09/04/2018)

via: SeekingAlpha at 2018-09-04 17:36:14:000

Top Gainers: COUP +12.4% . GBR +4.9% . RNET +4.2% . SMAR +4.1% . TSRO +4.1% . More news on: Coupa Software Inc, New Concept Energy, Inc., RigNet, Stocks on the move, , Read more … read more...

After Hours Gainers / Losers (09/04/2018)

via: SeekingAlpha at 2018-09-04 17:36:14:000

Top Gainers: COUP +12.4% . GBR +4.9% . RNET +4.2% . SMAR +4.1% . TSRO +4.1% . More news on: Coupa Software Inc, New Concept Energy, Inc., RigNet, Stocks on the move, , Read more … read more...

After Hours Gainers / Losers (09/04/2018)

via: SeekingAlpha at 2018-09-04 17:36:14:000

Top Gainers: COUP +12.4% . GBR +4.9% . RNET +4.2% . SMAR +4.1% . TSRO +4.1% . More news on: Coupa Software Inc, New Concept Energy, Inc., RigNet, Stocks on the move, , Read more … read more...

Applied Genetic Technologies Corporation: Near-Term Run Up Expected

via: SeekingAlpha at 2018-07-23 21:52:24:000

Shares of Applied Genetic Technologies Corporation ( AGTC ) are currently trading at about a third of the original IPO pricing of $12 per share, which took place in 2014. Year-to-date the stock price has risen by roughly 30%. Chart Figure 1: AGTC daily advanced chart (Source: Finviz… read more...

Applied Genetic Technologies Corporation: Near-Term Run Up Expected

via: SeekingAlpha at 2018-07-23 21:52:24:000

Shares of Applied Genetic Technologies Corporation ( AGTC ) are currently trading at about a third of the original IPO pricing of $12 per share, which took place in 2014. Year-to-date the stock price has risen by roughly 30%. Chart Figure 1: AGTC daily advanced chart (Source: Finviz… read more...

Applied Genetic Technologies Corporation: Near-Term Run Up Expected

via: SeekingAlpha at 2018-07-23 21:52:24:000

Shares of Applied Genetic Technologies Corporation ( AGTC ) are currently trading at about a third of the original IPO pricing of $12 per share, which took place in 2014. Year-to-date the stock price has risen by roughly 30%. Chart Figure 1: AGTC daily advanced chart (Source: Finviz… read more...

MeiraGTx IPO: Hedge Fund Managers Are Leading The Company

via: SeekingAlpha at 2018-06-04 05:17:45:000

With brilliant individuals inside MeiraGTx Holdings plc (MGTX), the institutional investors should have a look at the four candidates in Phase 1-2. Sophisticated underwriters, such as Bank of America Corporation (BAC), Barclays PLC (BCS), Evercore and Chardan, are working with the company. … read more...

MeiraGTx IPO: Hedge Fund Managers Are Leading The Company

via: SeekingAlpha at 2018-06-04 05:17:45:000

With brilliant individuals inside MeiraGTx Holdings plc (MGTX), the institutional investors should have a look at the four candidates in Phase 1-2. Sophisticated underwriters, such as Bank of America Corporation (BAC), Barclays PLC (BCS), Evercore and Chardan, are working with the company. … read more...

MeiraGTx IPO: Hedge Fund Managers Are Leading The Company

via: SeekingAlpha at 2018-06-04 05:17:45:000

With brilliant individuals inside MeiraGTx Holdings plc (MGTX), the institutional investors should have a look at the four candidates in Phase 1-2. Sophisticated underwriters, such as Bank of America Corporation (BAC), Barclays PLC (BCS), Evercore and Chardan, are working with the company. … read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Files To Raise $75 Million In IPO

via: SeekingAlpha at 2018-06-01 13:51:39:000

Quick Take MeiraGTx ( MGTX ) intends to raise $75 million from the sale of its ordinary shares, according to an amended S-1/A registration statement . The company is developing a pipeline of treatment candidates for various genetic diseases. MGTX is still in Phase 1 stage and is seeki… read more...

MeiraGTx Aims For $86 Million U.S. IPO

via: SeekingAlpha at 2018-05-18 11:44:30:000

Quick Take MeiraGTx ( MGTX ) intends to raise $86.25 million from the sale of its common stock in an IPO, according to a registration statement filed with the SEC. The firm is a clinical stage developer of gene therapies focused on diseases of the eye, salivary gland and central nervou… read more...

Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-11 22:07:07:000

Applied Genetic Technologies Corporation (AGTC) Q3 2018 Earnings Conference Call May 08, 2018 04:30 PM ET Executives Sue Washer - Chief Executive Officer Bill Sullivan - Chief Financial Officer Matt Feinsod - Chief Medical Officer Analysts Yanan Zhu - Wells Fargo Pete Sta… read more...

Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q3 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-05-11 22:07:07:000

Applied Genetic Technologies Corporation (AGTC) Q3 2018 Earnings Conference Call May 08, 2018 04:30 PM ET Executives Sue Washer - Chief Executive Officer Bill Sullivan - Chief Financial Officer Matt Feinsod - Chief Medical Officer Analysts Yanan Zhu - Wells Fargo Pete Sta… read more...

Applied Genetic misses by $0.04, misses on revenue

via: SeekingAlpha at 2018-05-08 16:31:34:000

Applied Genetic (NASDAQ: AGTC ): Q3 EPS of -$0.45 misses by $0.04 . Revenue of $3.6M (-57.1% Y/Y) misses by $1.97M . Shares -1% . Press Release More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , read more...

Applied Genetic misses by $0.04, misses on revenue

via: SeekingAlpha at 2018-05-08 16:31:34:000

Applied Genetic (NASDAQ: AGTC ): Q3 EPS of -$0.45 misses by $0.04 . Revenue of $3.6M (-57.1% Y/Y) misses by $1.97M . Shares -1% . Press Release More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , read more...

Notable earnings after Tuesday's close

via: SeekingAlpha at 2018-05-07 17:35:34:000

AAOI , AAXN , AGTC , ALEX , AMBC , APEI , ARNA , AVD , BECN , BIO , BOJA , BW , CA , CERS , CHUY , CISN , CLVS , CORT , CSOD , CTRE , CUTR , CVG , DEI , DIOD , DIS , DVAX , DXPE , EA , ECPG , EPR , ESE , ESIO , ETSY , EVC , EXTR , FANG , FARM , FOSL , … read more...

Notable earnings after Tuesday's close

via: SeekingAlpha at 2018-05-07 17:35:34:000

AAOI , AAXN , AGTC , ALEX , AMBC , APEI , ARNA , AVD , BECN , BIO , BOJA , BW , CA , CERS , CHUY , CISN , CLVS , CORT , CSOD , CTRE , CUTR , CVG , DEI , DIOD , DIS , DVAX , DXPE , EA , ECPG , EPR , ESE , ESIO , ETSY , EVC , EXTR , FANG , FARM , FOSL , … read more...

Finding Biotech Value In All-Time Highs

via: SeekingAlpha at 2018-02-10 00:56:27:000

Altum Research is about finding value. While I am definitely not complaining that biotech has rallied, some very interesting companies ([[SAGE]], [[FATE]], [[PIRS]], [[CBAY]], [[SGMO]], etc.) are just too high in price for me to put money in. However there is always value in biotech, sometimes… read more...

Finding Biotech Value In All-Time Highs

via: SeekingAlpha at 2018-02-10 00:56:27:000

Altum Research is about finding value. While I am definitely not complaining that biotech has rallied, some very interesting companies ([[SAGE]], [[FATE]], [[PIRS]], [[CBAY]], [[SGMO]], etc.) are just too high in price for me to put money in. However there is always value in biotech, sometimes… read more...

Finding Biotech Value In All-Time Highs

via: SeekingAlpha at 2018-02-10 00:56:27:000

Altum Research is about finding value. While I am definitely not complaining that biotech has rallied, some very interesting companies ([[SAGE]], [[FATE]], [[PIRS]], [[CBAY]], [[SGMO]], etc.) are just too high in price for me to put money in. However there is always value in biotech, sometimes… read more...

Finding Biotech Value In All-Time Highs

via: SeekingAlpha at 2018-02-10 00:56:27:000

Altum Research is about finding value. While I am definitely not complaining that biotech has rallied, some very interesting companies ([[SAGE]], [[FATE]], [[PIRS]], [[CBAY]], [[SGMO]], etc.) are just too high in price for me to put money in. However there is always value in biotech, sometimes… read more...

Finding Biotech Value In All-Time Highs

via: SeekingAlpha at 2018-02-10 00:56:27:000

Altum Research is about finding value. While I am definitely not complaining that biotech has rallied, some very interesting companies ([[SAGE]], [[FATE]], [[PIRS]], [[CBAY]], [[SGMO]], etc.) are just too high in price for me to put money in. However there is always value in biotech, sometimes… read more...

Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-02-09 09:57:06:000

Applied Genetic Technologies Corporation (AGTC) Q2 2018 Earnings Conference Call February 9, 2018 08:00 ET Executives Sue Washer - President and Chief Executive Officer Bill Sullivan - Chief Financial Officer Matt Feinsod - Chief Medical Officer Analysts Matthew Luchini - B… read more...

Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-02-09 09:57:06:000

Applied Genetic Technologies Corporation (AGTC) Q2 2018 Earnings Conference Call February 9, 2018 08:00 ET Executives Sue Washer - President and Chief Executive Officer Bill Sullivan - Chief Financial Officer Matt Feinsod - Chief Medical Officer Analysts Matthew Luchini - B… read more...

Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-02-09 09:57:06:000

Applied Genetic Technologies Corporation (AGTC) Q2 2018 Earnings Conference Call February 9, 2018 08:00 ET Executives Sue Washer - President and Chief Executive Officer Bill Sullivan - Chief Financial Officer Matt Feinsod - Chief Medical Officer Analysts Matthew Luchini - B… read more...

Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-02-09 09:57:06:000

Applied Genetic Technologies Corporation (AGTC) Q2 2018 Earnings Conference Call February 9, 2018 08:00 ET Executives Sue Washer - President and Chief Executive Officer Bill Sullivan - Chief Financial Officer Matt Feinsod - Chief Medical Officer Analysts Matthew Luchini - B… read more...

Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-02-09 09:57:06:000

Applied Genetic Technologies Corporation (AGTC) Q2 2018 Earnings Conference Call February 9, 2018 08:00 ET Executives Sue Washer - President and Chief Executive Officer Bill Sullivan - Chief Financial Officer Matt Feinsod - Chief Medical Officer Analysts Matthew Luchini - B… read more...

Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q2 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-02-09 09:57:06:000

Applied Genetic Technologies Corporation (AGTC) Q2 2018 Earnings Conference Call February 9, 2018 08:00 ET Executives Sue Washer - President and Chief Executive Officer Bill Sullivan - Chief Financial Officer Matt Feinsod - Chief Medical Officer Analysts Matthew Luchini - B… read more...

Applied Genetic EPS of -$0.29

via: SeekingAlpha at 2018-02-09 07:02:17:000

Applied Genetic (NASDAQ: AGTC ): Q2 EPS of -$0.29 may not be comparable to consensus of -$0.19. More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Applied Genetic EPS of -$0.29

via: SeekingAlpha at 2018-02-09 07:02:17:000

Applied Genetic (NASDAQ: AGTC ): Q2 EPS of -$0.29 may not be comparable to consensus of -$0.19. More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Applied Genetic EPS of -$0.29

via: SeekingAlpha at 2018-02-09 07:02:17:000

Applied Genetic (NASDAQ: AGTC ): Q2 EPS of -$0.29 may not be comparable to consensus of -$0.19. More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Applied Genetic EPS of -$0.29

via: SeekingAlpha at 2018-02-09 07:02:17:000

Applied Genetic (NASDAQ: AGTC ): Q2 EPS of -$0.29 may not be comparable to consensus of -$0.19. More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Applied Genetic EPS of -$0.29

via: SeekingAlpha at 2018-02-09 07:02:17:000

Applied Genetic (NASDAQ: AGTC ): Q2 EPS of -$0.29 may not be comparable to consensus of -$0.19. More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Applied Genetic EPS of -$0.29

via: SeekingAlpha at 2018-02-09 07:02:17:000

Applied Genetic (NASDAQ: AGTC ): Q2 EPS of -$0.29 may not be comparable to consensus of -$0.19. More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

After Hours Gainers / Losers

via: SeekingAlpha at 2017-12-14 17:35:04:000

Top gainers: DCIX +23.6% . DDR +10.6% . HES +6.1% . QNST +5.1% . RIGL +5.0% . More news on: Diana Containerships Inc., DDR Corp., Hess Corporation, Stocks on the move, Read more … read more...

After Hours Gainers / Losers

via: SeekingAlpha at 2017-12-14 17:35:04:000

Top gainers: DCIX +23.6% . DDR +10.6% . HES +6.1% . QNST +5.1% . RIGL +5.0% . More news on: Diana Containerships Inc., DDR Corp., Hess Corporation, Stocks on the move, Read more … read more...

Editors' Picks Daily: Is Downsizing A Fad?

via: SeekingAlpha at 2017-11-13 09:00:00:000

Note: Subscribers to SA Editors' Picks Plus got an early look at this article. Each article listed below has been selected by our editorial staff as a widely appealing and highly convincing analysis with a clear actionable takeaway. Please use the comment box at the end of this article to … read more...

Editors' Picks Daily: Is Downsizing A Fad?

via: SeekingAlpha at 2017-11-13 09:00:00:000

Note: Subscribers to SA Editors' Picks Plus got an early look at this article. Each article listed below has been selected by our editorial staff as a widely appealing and highly convincing analysis with a clear actionable takeaway. Please use the comment box at the end of this article to … read more...

Applied Genetic Technologies Corp.: A Forgotten Net-Net With Clear Upside Catalysts

via: SeekingAlpha at 2017-11-10 09:58:10:000

Applied Genetic Technologies Corp. ( AGTC ) is a clinical stage biotech company developing therapies for patients with inherited diseases. AGTC has developed a proprietary gene therapy platform that the company has initially used to focus on ophthalmology. AGTC has initially targeted orphan … read more...

Applied Genetic Technologies Corp.: A Forgotten Net-Net With Clear Upside Catalysts

via: SeekingAlpha at 2017-11-10 09:58:10:000

Applied Genetic Technologies Corp. ( AGTC ) is a clinical stage biotech company developing therapies for patients with inherited diseases. AGTC has developed a proprietary gene therapy platform that the company has initially used to focus on ophthalmology. AGTC has initially targeted orphan … read more...

Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q1 2018 Results - Earnings Call Transcript

via: SeekingAlpha at 2017-11-07 20:10:41:000

Applied Genetic Technologies Corporation (AGTC) Q1 2018 Earnings Conference Call November 07, 2017 04:30 PM ET Executives Sue Washer - President and CEO Matthew Feinsod - CMO Bill Sullivan - CFO Analysts Matthew Luchini - BMO Capital Markets Mara Goldstein - Cantor Fitzge… read more...

Applied Genetic beats by $0.01, beats on revenue

via: SeekingAlpha at 2017-11-07 16:47:14:000

Applied Genetic (NASDAQ: AGTC ): Q1 EPS of -$0.08 beats by $0.01 . Revenue of $10.32M (-12.6% Y/Y) beats by $1.88M . Shares +1.5% . Press Release More news on: Applied Genetic Technologies Corporation, Earnings news and commentary, Stocks on the move, Healthcare stocks news, , … read more...

Notable earnings after Tuesday's close

via: SeekingAlpha at 2017-11-06 17:35:57:000

AAOI , AAXN , ACAD , AFAM , AGTC , AGU , ALDR , ALEX , ALNY , AMED , APEI , APPS , ARNA , AXAS , BEAT , BETR , BUFF , CALX , CGBD , CHMI , CLI , CLR , COHR , CRZO , CSRA , CUTR , CVCO , CVG , CVNA , DAR , DCP , DEI , DEPO , DIOD , DOOR , DVA , EDIT , EL… read more...

Premarket analyst action - healthcare

via: SeekingAlpha at 2017-09-14 07:16:14:000

Ultragenyx (NASDAQ: RARE ) upgraded to Outperform by Wedbush. More news on: Ultragenyx Pharmaceutical Inc., Agile Therapeutics, Inc., OPKO Health, Inc., Healthcare stocks news, Read more … read more...

Midday Gainers / Losers

via: SeekingAlpha at 2017-09-13 12:49:29:000

Gainers: SNAK +24% . EGAN +24% . MYOS +23% . AKTX +20% . TRXC +18% . LOXO +18% . EGO +17% . BLDP +17% . SIEN +17% . AMRS +15% . More news on: Inventure Foods, Inc., eGain Communications Corp., MYOS RENS Technology, Stocks on the move, Read more … read more...

Applied Genetic Technologies' (AGTC) CEO Sue Washer on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2017-09-13 12:49:05:000

Applied Genetic Technologies Corporation (AGTC) Q4 2017 Earnings Conference Call September 13, 2017 08:00 AM ET Executives Sue Washer - President and Chief Executive Officer Matthew Feinsod - Chief Medical Officer William Sullivan - Chief Financial Officer Analysts Matthew … read more...

Applied Genetic reports Q4 results

via: SeekingAlpha at 2017-09-13 07:11:36:000

Applied Genetic ( AGTC ) Q4 results : Revenues: $8.3M (-31.4%); Operating Loss: ($2.8M); Net Loss: ($3.2M); Loss Per Share: ($0.18); Quick Assets: $30.7M (+6.2%). More news on: Applied Genetic Technologies Corporation, Healthcare stocks news, Earnings news and commentary, , Read more … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided for free by IEX